A Chinese company that developed the country’s first homegrown Alzheimer’s disease therapy has suspended production of the drug, a local media report said, casting doubts on the treatment’s future nearly five years after its approval.
www.bloomberg.com
#Chinese #Firm #Halts #Production #Controversial #Alzheimers #Drug
Chinese Firm Halts Production of Controversial Alzheimer’s Drug
